A Cost-Effectiveness Analysis of Newborn Screening for Severe Combined Immunodeficiency in the UK

• Главные авторы: Alice Bessey (Автор), James Chilcott (Автор), Joanna Leaviss (Автор), Carmen de la Cruz (Автор), Ruth Wong (Автор)
• Формат: ‌
• Опубликовано: MDPI AG, 2019-08-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Severe combined immunodeficiency (SCID) can be detected through newborn bloodspot screening. In the UK, the National Screening Committee (NSC) requires screening programmes to be cost-effective at standard UK thresholds. To assess the cost-effectiveness of SCID screening for the NSC, a decision-tree...